BRYAT:BISTBorusan Yatirim ve Pazarlama AS Analysis
Data as of 2026-05-23 - not real-time
TRY 1,940.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at 1,940 TRY, well below its 20‑day (2,082.2), 50‑day (2,138.8) and 200‑day (2,273.9) simple moving averages, indicating a clear bearish price position. Momentum metrics reinforce this view: the 14‑day RSI sits at 37.4, below the 40 threshold, and the MACD line is negative (-60.7) with a bearish signal crossing the signal line at -39.7. Trading volume has been on a downward trend, and the price is hovering just above the identified support level of 1,800 while facing resistance near 2,277. Despite the technical weakness, the fundamentals paint a contrasting picture: a discounted DCF fair value of 3,460 TRY suggests the market is pricing the shares at roughly 44% discount to intrinsic value. The company boasts a robust dividend yield of 8.56% with a modest payout ratio of 35.5%, supported by ample cash reserves and zero net debt. Operating margins are healthy (> 67%) and free cash flow remains positive, underscoring strong cash generation capacity. However, the sector’s cyclical nature, elevated 30‑day volatility of 39.9%, and Turkey’s macro‑economic environment introduce medium‑to‑high risks that temper the upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major SMAs indicating bearish short‑term momentum
- RSI and MACD signaling oversold conditions but no clear reversal
- Attractive dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation suggests ~44% upside
- Zero debt and strong free cash flow support earnings stability
- Sustainable dividend enhances total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term undervaluation relative to intrinsic value
- Consistent profitability and high payout ratio
- Potential sector recovery and dividend compounding over time
Key Metrics & Analysis
Financial Health
Revenue Growth107.90%
Profit Margin2386.02%
P/E Ratio11.8
ROE14.16%
ROA7.78%
P/B Ratio1.6
Op. Cash FlowTRY-1354174720
Free Cash FlowTRY2.5B
Technical Analysis
TrendBearish
RSI37.4
SupportTRY 1,800.00
ResistanceTRY 2,277.00
MA 20TRY 2,082.20
MA 50TRY 2,138.80
MA 200TRY 2,273.93
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueTRY 3,460.65
GradeUndervalued
TypeValue
Dividend Yield8.56%
Risk Assessment
Beta0.39
Volatility39.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.